Welcome to the first episode of the Biotech Bytes podcast! Today, we have an insightful conversation with Bill Wallace from Intercept Pharmaceuticals, exploring the transformative role of AI in the pharmaceutical and biotech industries.Bill talks about how working together and keeping data safe are key in these industries. He dives into the specific challenges the industry faces, like making sure smaller companies can access data and adapting to the new things AI can do.We also touch on the critical role of AI in patient safety and drug development, while addressing the challenges of data protection.As we navigate through this conversation, it becomes evident that the integration of AI in pharma and biotech is a delicate balancing act. It requires an approach that harmonizes innovation with prudence.Join us to discover how AI is making a significant impact in the pharma and biotech industries. This episode is going to give you a great look into how AI is really shaking things up in our industry. Tune in to learn all about it!Specifically, this episode highlights the following themes:The integral role of AI in advancing pharmaceutical research and patient careConfronting cybersecurity challenges in an AI-enhanced pharmaceutical industryNavigating the financial and strategic landscape for AI adoption in varying company sizesLinks from this episode:Get to know more about Steven Swan: https://www.linkedin.com/in/swangroupGet to know more about Bill Wallace: https://www.linkedin.com/in/williamwallace2Learn more about Intercept: https://www.interceptpharma.com

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related